Iovance Biotherapeutics Inc
(IOVA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 10,210 | 12,556 | 111,280 | 44,909 | 17,190 |
| Marketable Securities | 99,936 | 99,780 | N/A | N/A | N/A |
| TOTAL | $110,391 | $112,715 | $111,409 | $44,975 | $17,231 |
| Non-Current Assets | |||||
| PPE Net | 1,833 | 2,025 | 2,128 | 1,532 | 171 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 15 |
| TOTAL | $1,833 | $2,025 | $2,128 | $1,532 | $186 |
| Total Assets | $112,224 | $114,740 | $113,538 | $46,507 | $17,417 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,161 | 1,157 | 1,107 | 1,248 | 574 |
| Accrued Expenses | 1,694 | 709 | 803 | 414 | 685 |
| TOTAL | $2,855 | $1,866 | $1,911 | $1,662 | $1,259 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $2,855 | $1,866 | $1,911 | $1,662 | $1,259 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 47,834 | 47,192 | 45,030 | 44,082 | 27,640 |
| Common Shares | 247 | 247 | 247 | 247 | 246 |
| Retained earnings | -95,845 | -88,228 | -81,860 | -76,562 | -71,695 |
| Other shareholders' equity | 38 | 22 | 0 | 0 | 0 |
| TOTAL | $109,369 | $112,873 | $111,627 | $44,845 | $16,158 |
| Total Liabilities And Equity | $112,224 | $114,740 | $113,538 | $46,507 | $17,417 |